IRX Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
IRX Therapeutics, Inc. - overview
Established
1994
Location
New York, NY, US
Primary Industry
Biotechnology
About
Founded in 1994 and is based in New York, US, IRX Therapeutics, Inc. operates as a biotechnology company that engages in the discovery and development of immune therapies for the treatment of cancer and viral diseases.
Current Investors
Lilly Ventures, Astellas Venture Management
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Epidemiology
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.